These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2893280)

  • 1. Intrathecal dynorphin A (1-13) and (3-13) reduce spinal cord blood flow by non-opioid mechanisms.
    Long JB; Kinney RC; Malcolm DS; Graeber GM; Holaday JW
    NIDA Res Monogr; 1986; 75():524-6. PubMed ID: 2893280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal dynorphin A1-13 and dynorphin A3-13 reduce rat spinal cord blood flow by non-opioid mechanisms.
    Long JB; Kinney RC; Malcolm DS; Graeber GM; Holaday JW
    Brain Res; 1987 Dec; 436(2):374-9. PubMed ID: 2893653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic function.
    Long JB; Petras JM; Mobley WC; Holaday JW
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1167-74. PubMed ID: 2901487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses.
    Long JB; Mobley WC; Holaday JW
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1158-66. PubMed ID: 2901486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine8-vasopressin reduces spinal cord blood flow after spinal subarachnoid injection in rats.
    Long JB; Martinez-Arizala A; Johnson SH; Holaday JW
    J Pharmacol Exp Ther; 1989 May; 249(2):499-506. PubMed ID: 2524587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulators of pain in the spinal cord.
    Jen MF; Lu CH; Huang L; Han JS
    NIDA Res Monogr; 1986; 75():457-60. PubMed ID: 2893278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies of the neuro-excitatory behavioural effects of morphine-3-glucuronide and dynorphin A(2-17) following spinal and supraspinal routes of administration.
    Hemstapat K; Le L; Edwards SR; Smith MT
    Pharmacol Biochem Behav; 2009 Oct; 93(4):498-505. PubMed ID: 19580825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury.
    Long JB; Rigamonti DD; Oleshansky MA; Wingfield CP; Martinez-Arizala A
    J Pharmacol Exp Ther; 1994 Apr; 269(1):358-66. PubMed ID: 7909561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin causes vasoconstriction, reduces blood flow and increases vascular permeability in the rat central nervous system.
    Long JB; Rigamonti DD; Dosaka K; Kraimer JM; Martinez-Arizala A
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1425-32. PubMed ID: 1347570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurologic deficits and neuronal injury in rats resulting from nonopioid actions of the delta opioid receptor antagonist ICI 174864.
    Long JB; Petras JM; Holaday JW
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1169-77. PubMed ID: 2908046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury.
    Faden AI
    Ann Neurol; 1990 Jan; 27(1):67-74. PubMed ID: 1967925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynorphin-A-(1-13) antagonizes morphine analgesia in the brain and potentiates morphine analgesia in the spinal cord.
    Ren MF; Lu CH; Han JS
    Peptides; 1985; 6(6):1015-20. PubMed ID: 2871545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous opioid immunoreactivity in rat spinal cord following traumatic injury.
    Faden AI; Molineaux CJ; Rosenberger JG; Jacobs TP; Cox BM
    Ann Neurol; 1985 Apr; 17(4):386-90. PubMed ID: 2860844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynorphin A (1-13): in vivo opioid antagonist actions and non-opioid anticonvulsant effects in the rat flurothyl test.
    Tortella FC; Holaday JW
    NIDA Res Monogr; 1986; 75():539-42. PubMed ID: 2893282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of dynorphin (1-13) on spinal reflexes in the rat.
    Caudle RM; Isaac L
    J Pharmacol Exp Ther; 1988 Aug; 246(2):508-13. PubMed ID: 2900326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynorphin A-(1-17) induces alterations in free fatty acids, excitatory amino acids, and motor function through an opiate-receptor-mediated mechanism.
    Bakshi R; Newman AH; Faden AI
    J Neurosci; 1990 Dec; 10(12):3793-800. PubMed ID: 1980130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive and non-competitive NMDA antagonists limit dynorphin A-induced rat hindlimb paralysis.
    Bakshi R; Faden AI
    Brain Res; 1990 Jan; 507(1):1-5. PubMed ID: 1967971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRH fails to antagonize the acute paralytic effects of intrathecal dynorphin A and substance P antagonists in the rat.
    Martinez-Arizala A; Long JB; Holaday JW
    Brain Res; 1988 Nov; 473(2):385-8. PubMed ID: 2466528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous opioids in spinal cord injury: a critical evaluation.
    Long JB; Martinez-Arizala A; Petras JM; Holaday JW
    Cent Nerv Syst Trauma; 1986; 3(4):295-315. PubMed ID: 2884046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hindlimb paralytic effects of prodynorphin-derived peptides following spinal subarachnoid injection in rats.
    Long JB; Martinez-Arizala A; Echevarria EE; Tidwell RE; Holaday JW
    Eur J Pharmacol; 1988 Aug; 153(1):45-54. PubMed ID: 2905665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.